Non Follicular Indolent Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non Follicular Indolent Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-23Clinical Trial Update: Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial assessing efficacy and safety of umbralisib in non-follicular indolent non-Hodgkin lymphoma has completed with results posted …